InterviewsMarch 2, 2021 Investing in Psychedelic Medicine and Sustainable Solutions for Mental Health and Well Being
InterviewsJanuary 15, 2021 Journey Colab: Including Traditional Communities in the Plant-Based Medicine Boom
InterviewsJanuary 8, 2021 Fluence: Training the Next Generation of Psychedelic Treatment Professionals
InterviewsDecember 23, 2020 CaaMTech: Utilizing the Entourage Effect to Transform Psychedelic Medicine
InterviewsDecember 18, 2020 Back of the Yard Algae Sciences: Toward the First Vertically Integrated Psychedelic Producer
InterviewsDecember 11, 2020 Greenway DNA: Leveraging DNA to Solve the Dosing Challenge in Natural Medicine
InterviewsNovember 6, 2020 Havn Life Sciences: Supplying the Compounds to Support the Future of Psychedelic Medicine
InterviewsOctober 23, 2020 Mr. Psychedelic Law: Addressing Psychedelic Decriminalization on a City-by-City Basis
InterviewsOctober 14, 2020 Psilera Bioscience: Developing the Next Generation of Safer, Targeted Psychedelic Therapies
InterviewsOctober 8, 2020 CB Therapeutics: Is Fermentation the Answer to Scaling Psychedelic Production?
InterviewsAugust 20, 2020 A New Approach to Psilocybin Production That’s Cheaper and More Precise: Mimosa CEO Jim Keim
InterviewsAugust 14, 2020 Fighting Depression with Targeted, Next Generation Psychedelics: A Conversation with Bright Minds CEO Ian McDonald
